Killian Meara

Check out these top featured stories from Drug Topics in June 2024.

The strongest independent predictors of becoming adherent to dermatology follow-up included younger age and prior outpatient visits.

Check out important updates from the FDA for the week of June 17.

Patrick Alonso, PharmD, CPh, owner and manager of Your Tampa Health Care Advocates, talks about how to build trust with male patients, what health screenings men should be getting, and how pharmacists can help support men’s mental health.

Research presented at ASHP 2024 found that concerns around the safety of COVID-19 vaccines and the credibility of information from public health authorities were the biggest drivers of vaccine hesitancy during the COVID-19 pandemic.

A poster presented at AHS 2024 found that older patients tended to have more vitamin deficiencies compared to younger patients.

A survey of health system specialty pharmacy employees found that hybrid work significantly improved quality of life and workplace productivity.

A posted presented at ASHP 2024 examined if improved access to methadone could decrease hospital length of stay and readmission rates.

Skin complications are common in patients with diabetes, but pharmacists can recommend several easy measures to help.

Sam Clark, MD, PhD, founder and CEO of Terran Biosciences, discusses what the future looks like for psychedelic treatments.

Sandra C. Canally, RN, founder and CEO of The Compliance Team, discussed the goals, benefits, and opportunities of value-based care in pharmacy.

Patrick Alonso, PharmD, CPh, discusses how pharmacists' skills are underutilized and how they can help support men’s health.

Two posters presented at ENDO 2024 assessed semaglutide’s impact on taste sensitivity and tirzepatide’s role in body weight reduction.

Patrick Alonso, PharmD, CPh, provides some tips for men looking to improve their overall mental health.

Check out important updates from the FDA for the week of June 10.

The therapy from AstraZeneca is indicated to improve glycemic control in patients aged 10 years or older.

Patrick Alonso, PharmD, CPh, discusses how pharmacists can support men dealing with mental health issues and lifestyle changes he recommends to male patients to improve overall health.

Patients with advanced cancer can experience malignant wounds, which can have a negative impact on quality of life.

Patrick Alonso, PharmD, CPh, owner and manager of BlueZone Health Care Advocates and co-host of the Men’s Health Unscripted podcast, talks about how health care providers can build trust with male patients and what screenings men at different ages should be having.

The Lingo and Libre Rio from Abbott are based on the company’s FreeStyle Libre sensing technology.

Sam Clark, MD, PhD, founder and CEO of Terran Biosciences, discusses how some of the concern’s raised by the panel can inform future psychedelic research.

In a study presented at ASCO 2024, investigators found that all 20 included patients with early stage breast cancer receiving chemotherapy developed hyperglycemia.

Sam Clark, MD, PhD, founder and CEO of Terran Biosciences, talks about some of the problems he saw during the Psychopharmacologic Drugs Advisory Committee meeting.

Check out important updates from the FDA for the week of June 3.

Vaccinated men and women are at a reduced risk for HPV-related cancers, according to research presented at ASCO 2024.

HbA1c levels decreased significantly after an average of 154 days in patients who used a continuous glucose monitor.

Four poster presented at ENDO 2024 examined the current landscape of diabetes.

The Psychopharmacologic Drugs Advisory Committee voted 10-1 that the benefits of MDMA do not outweigh its potential risks.

Posters presented at ENDO 2024 investigated excessive weight gain in breast cancer survivors and how high insulin levels impact outcomes for Black women with an aggressive form of the disease.

Research presented at ENDO 2024 found that glucagon-like peptide-1 receptor agonists had a lower acute pancreatitis recurrence risk than SGLT2i, DPP4i, and no medication.